1997
DOI: 10.1006/bbrc.1997.7322
|View full text |Cite
|
Sign up to set email alerts
|

Prolactin Stimulates Mitogen-Activated Protein Kinase in Human Leiomyoma Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
11
0

Year Published

2001
2001
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 35 publications
1
11
0
Order By: Relevance
“…On the other hand, there was no significant difference between the groups in the proportion of women who had had a cumulative lactation period over 9 months with the values falling in relatively close range (32.9 vs. 42.24%; table 2). Overall, these findings support the previous hypothesis stating that prolactin, the most prominent hormone during lactation, may increase the risk for development of fibroid tumors [23]. …”
Section: Discussionsupporting
confidence: 91%
“…On the other hand, there was no significant difference between the groups in the proportion of women who had had a cumulative lactation period over 9 months with the values falling in relatively close range (32.9 vs. 42.24%; table 2). Overall, these findings support the previous hypothesis stating that prolactin, the most prominent hormone during lactation, may increase the risk for development of fibroid tumors [23]. …”
Section: Discussionsupporting
confidence: 91%
“…The diverse activities of PRL are mediated by its receptor (PRLR) and this molecule evokes the activation of several signaling pathways including Jak2-STAT [3], PI3K [4], and MAPK [5,6]. There are multiple isoforms of the PRLR in humans; the long form (LF), intermediate (IF), and two short forms (SF1a and SF1b) are produced by alternative splicing [7].…”
Section: Introductionmentioning
confidence: 99%
“…The putative genomic signaling pathways of PRL in mammary glandular epithelia, neurons and liver appeared to involve Janus kinase-2 (JAK2) signal transducers and activator of transcription (STAT)5, phosphoinositide 3-kinase (PI3K), and mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK) pathways (6,30,42,55,62). However, nongenomic cascades of JAK2, PI3K, and MEK have also been demonstrated as sig-naling pathways of PRL in several tissues, including mammary epithelia (1,47,51).…”
mentioning
confidence: 99%